Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
| Status: | Recruiting | 
|---|---|
| Conditions: | Women's Studies, Women's Studies | 
| Therapuetic Areas: | Reproductive | 
| Healthy: | No | 
| Age Range: | 18 - Any | 
| Updated: | 3/2/2017 | 
| Start Date: | March 2016 | 
| End Date: | December 2017 | 
| Contact: | Kevin O'Shea | 
| Email: | koshea@illumina.com | 
| Phone: | 6502042231 | 
Prospective Collection of Whole Blood Specimens of Subjects Diagnosed With Preterm Preeclampsia and/or Fetal Growth Restriction in Support of a Molecular Assay Development
Sample Collection Study
			This is a limited prospective collection of whole blood samples from pregnant women with a
diagnosis of preterm preeclampsia and/or fetal growth restriction in addition to samples
from a control group to aid in the development of a Next Generation Sequencing (NGS)-based
assay to detect molecular markers associated with preterm preeclampsia.
diagnosis of preterm preeclampsia and/or fetal growth restriction in addition to samples
from a control group to aid in the development of a Next Generation Sequencing (NGS)-based
assay to detect molecular markers associated with preterm preeclampsia.
Inclusion Criteria:
- Women 18 years of age or older at enrollment
- Pregnant women with a viable singleton gestation
- Able to provide written, informed consent
- Able to provide 20 mL of whole blood
- Diagnosis of preeclampsia and/or diagnosis of fetal growth restriction
- Preeclampsia; Diastolic Blood Pressure ≥110mmHg on at least 2 occasions 4 hours apart
while on bed rest, but before the onset of labor with Proteinuria; Excretion of
≥300mg/24hr (24 hour collection) of protein or a timed excretion that is extrapolated
to the 24 hour urine value or a protein/creatinine [both in mg/dL] ratio of at least
0.3 or the qualitative determination (urine dipstick) of ≥ 1+
- Fetal Growth Restriction; Estimated fetal weight or abdominal circumference by
ultrasound at ≥ 19 0/7 weeks gestational age < 5%ile or 5-10%ile with abnormal
umbilical artery Doppler examination (>95%ile, absent end diastolic flow or reverse
end diastolic flow)
- Gestational age between 20 to 36 weeks 6 days determined by ultrasound and/or LMP per
ACOG guidelines1
Exclusion Criteria:
- Known malignancy
- History of maternal organ or bone marrow transplant
- Maternal blood transfusion in the last 8 weeks
- Any hypertension diagnosed prior to current pregnancy
- Diabetes
- Fetal anomaly or known chromosome abnormality
- Thrombocytopenia (< 100,000 plts/mL)
- Impaired liver function (AST/ALT 2X ULN)
- Newly developed renal insufficiency (serum creatinine >1.1 mg/dL or a doubling of
serum creatinine in the absence of other renal disease)
- Pulmonary edema
- New onset cerebral disturbances or visual scotomata
We found this trial at
    10
    sites
	
								New York, New York 10065			
	
			
					Principal Investigator: Ronald Wapner
			
						
										Phone: 212-305-2158
					Click here to add this to my saved trials
	 
  
									800 Washington St
Boston, Massachusetts 02111
	
			Boston, Massachusetts 02111
(617) 636-5000
							 
					Principal Investigator: Errol Norwitz, MD
			
						
										Phone: 617-636-0186
					
		Tufts Medical Center Tufts Medical Center is an internationally-respected academic medical center – a teaching...  
  
  Click here to add this to my saved trials
	 
  
									 301 University Blvd
Galveston, Texas 77555
	
			Galveston, Texas 77555
(409) 772-1011
							 
					Principal Investigator: George Saade, MD
			
						
								
		University of Texas Medical Branch Established in 1891 as the University of Texas Medical Department,...  
  
  Click here to add this to my saved trials
	 
  
								Flushing, New York 11355			
	
			
					Principal Investigator: Daniel Skupski
			
						
										Phone: 718-670-1707
					Click here to add this to my saved trials
	 
  
									254 Easton Ave
New Brunswick, New Jersey 08901
	
			New Brunswick, New Jersey 08901
(732) 745-8600
							 
					Principal Investigator: Angela Ranzini
			
						
										Phone: 732-339-7602
					
		Saint Peter's University Hospital Located in New Brunswick, NJ, Saint Peter's University Hospital has been...  
  
  Click here to add this to my saved trials
	 
  
									259 1st Street
New York, New York 11501
	
			
					New York, New York 11501
Principal Investigator: Jolene Muscat
			
						
										Phone: 510-663-9582
					Click here to add this to my saved trials
	 
  
								Newark, Delaware 19718			
	
			
					Principal Investigator: Kelly Ruhstaller
			
						
										Phone: 302-733-2379
					Click here to add this to my saved trials
	 
  
									1427 Vine Street
Philadelphia, Pennsylvania 19102
	
			
					Philadelphia, Pennsylvania 19102
Principal Investigator: Lauren Plante
			
						
										Phone: 215-762-8582
					Click here to add this to my saved trials
	 
  
								Piscataway, New Jersey 08854			
	
			
					Principal Investigator: Christina Duzyj-Buniak
			
						
										Phone: 732-235-6630
					Click here to add this to my saved trials
	 
  
									239 Hurffville Crosskeys Road
Sewell, New Jersey 08080
	
			
					Sewell, New Jersey 08080
Principal Investigator: Ronald Librizzi
			
						
										Phone: 856-291-8875
					Click here to add this to my saved trials
	